Skip to main content

New Product Watch: Jan 6, 2009

Premium
Ariadne announced that its Pathway Studio software is now interoperable with Illumina’s GenomeStudio data analysis software for second-generation sequencing. Pathway Studio can analyze data from both the iScan and BeadArray Reader platforms, Ariadne said.
 
“Ariadne is the first to offer a plug-in with our newly launched GenomeStudio Software program,” Omoshile Clement, senior product manager of software informatics at Illumina, said in a statement. “By providing a graphical representation of Illumina’s microarray data, Pathway Studio offers researchers a unique way to complete advanced downstream analysis.”
 
Pathway Studio is a bench-top application that uses proprietary algorithms to perform functional analysis, identify regulated pathways, or discover new biological networks.
 

 
The Broad Institute of MIT and Harvard has released version 1.2 of its Integrative Genomics Viewer visualization tool for large genomic data sets.
 
The Broad said the release includes several new genomes, including Plasmodium falciparum, Neurospora crassa, and S. pombe.
 
Another new feature is that users can import genomes of their choice directly into IGV.
 
IGV now supports General Feature Format (GFF2, GFF3) and Wiggle (WIG) files and supports probe identifiers. When loading a GCT or RES file, IGV now recognizes Affymetrix, Agilent, and Illumina probe identifiers and automatically places the gene expression data at the correct loci.
 
IGV 1.2 can be downloaded here

The Scan

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.